Papers
7
Total Citations
50
H-Index
4
About
Mark S. Litwin is a leading urologic oncologist and health services researcher whose work centers on improving surgical outcomes and quality of care for men with genitourinary cancers. His major contributions include pioneering the use of patient-reported outcomes to compare retropubic, laparoscopic, and robot-assisted prostatectomy, demonstrating how surgical approach affects health-related quality of life and patient satisfaction. He also advanced perioperative quality indicators for prostate cancer surgery, helping to establish evidence-based benchmarks for care. In bladder cancer, Litwin developed and validated an automated natural language processing method to identify patients undergoing radical cystectomy, a tool that enhances quality measurement and case identification from electronic health records. His research on financial margins for prostate cancer surgery quantified the impact of modifiable cost inputs within episode-based reimbursement models, informing value-based care. With over 20 citations on his multi-institutional study of robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumors, Litwin’s work has shaped surgical practice and health policy. His investigations into readmissions after radical nephrectomy and the effects of cancer treatment on spouses further underscore his commitment to comprehensive, patient-centered outcomes research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Readmissions after radical nephrectomy in a national cohort2 citations · 2023